By Thomas Catenacci -
The single-dose coronavirus vaccine developed by American company Johnson & Johnson generated a positive immune response and is safe, according to early trial results the company released Wednesday. Johnson & Johnson’s (J&J) vaccine “gives sustainable antibodies,” Dr. Paul Stoffels, the company’s chief scientific officer at J&J, told CNBC of the vaccine’s early trial results, which …
One-Dose Coronavirus Vaccine Trial Shows Positive Results, Company Says is original content from Conservative Daily News - Where Americans go for news, current events and commentary they can trust - Conservative News Website for U.S. News, Political Cartoons and more.
